Ads
related to: Pfizer
Search results
Fact Check: Joel Osteen Rumor Claims He's Leaving Ministry After Event Organizers Kicked Him Out of...
Snopes· 2 days agoOn June 12, 2024, Snopes looked into a rumor claiming Joel Osteen — the leader of the Houston, Texas...
Market Today: Boeing Delays 737 Production, Pfizer Extends Losse
Guru Focus· 13 hours agoMarket Performance Overview The S&P 500 and Nasdaq Composite hit fresh record highs this week,...
Pfizer study finds Paxlovid ineffective against Long COVID despite federal research funds
22 WSBT South Bend· 3 days agoLong COVID is a chronic condition resulting from an initial infective with COVID-19, according to...
Sarepta Therapeutics gains as Pfizer failure removes overhang By Investing.com
Investing.com· 2 days agoSarepta Therapeutics (NASDAQ:SRPT) stock rose over 3% Thursday after Pfizer (NYSE:PFE) announced...
UPDATE: Pfizer's phase 3 gene therapy trial fails to improve function for boys with Duchenne...
FierceBiotech· 3 days agoPfizer’s phase 3 gene therapy trial has failed to demonstrate significant improvement in motor...
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
Motley Fool via Yahoo Finance· 7 days agoHere's why they picked Gilead Sciences (NASDAQ: GILD), Organon (NYSE: OGN), and Pfizer (NYSE: PFE)....
Pfizer's gene-therapy trial failure boosts Sarepta's stock
Morningstar· 2 days agoShares of Sarepta Therapeutics Inc. (SRPT) gained 4% premarket on Thursday after a potential competitor to its gene therapy stumbled in a late-stage trial. Pfizer Inc. said ...
Pentagon ran secret anti-vax campaign to undermine China during pandemic
Fox News· 15 hours agoAt the height of the COVID-19 pandemic, the U.S. military launched a secret campaign to counter what...
Pfizer's Duchenne gene therapy fails in late-stage study
Reuters· 3 days agoThe therapy also did not show a significant difference compared to placebo in secondary goals of the...
Sarepta’s stock gains after Pfizer’s Duchenne trial failure - Boston Business Journal
The Business Journals· 2 days agoPharma giant Pfizer Inc. (NYSE: PFE) announced on Wednesday after markets closed that its gene...